FMR LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$8,019,000
-32.5%
1,278,929
-13.4%
0.00%0.0%
Q2 2018$11,877,000
+8.1%
1,477,229
+0.3%
0.00%0.0%
Q1 2018$10,983,000
-0.5%
1,472,229
-20.6%
0.00%0.0%
Q4 2017$11,038,000
-38.7%
1,855,156
-24.2%
0.00%
-50.0%
Q3 2017$18,011,000
-0.7%
2,447,156
-8.4%
0.00%0.0%
Q2 2017$18,131,000
-35.7%
2,670,196
-10.6%
0.00%
-50.0%
Q1 2017$28,208,000
-8.8%
2,988,126
-16.5%
0.00%0.0%
Q4 2016$30,933,000
+41.2%
3,580,156
+3.4%
0.00%
+33.3%
Q3 2016$21,909,000
+55.3%
3,461,156
+3.5%
0.00%
+50.0%
Q2 2016$14,108,000
-24.3%
3,343,223
-21.8%
0.00%
-33.3%
Q1 2016$18,645,000
-42.0%
4,276,279
-18.4%
0.00%
-25.0%
Q4 2015$32,135,000
+5.4%
5,242,279
-1.7%
0.00%0.0%
Q3 2015$30,500,000
-22.0%
5,332,151
+1.7%
0.00%
-20.0%
Q2 2015$39,107,000
+19.9%
5,242,279
-3.9%
0.01%
+25.0%
Q1 2015$32,618,000
-17.7%
5,454,546
+4.0%
0.00%
-20.0%
Q4 2014$39,632,000
+51.4%
5,242,279
+3.9%
0.01%
+25.0%
Q3 2014$26,176,000
+49.0%
5,043,542
+23.7%
0.00%
+100.0%
Q2 2014$17,568,000
-2.5%
4,076,046
-7.5%
0.00%
-33.3%
Q1 2014$18,020,000
-45.2%
4,405,946
-28.6%
0.00%
-40.0%
Q4 2013$32,892,000
-25.3%
6,171,046
-29.5%
0.01%
-28.6%
Q3 2013$44,054,000
+16.2%
8,758,346
+3.0%
0.01%
+16.7%
Q2 2013$37,924,0008,503,2460.01%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders